ASH: A+AVD Beats ABVD for Advanced Hodgkin's Lymphoma
Lower combined risk of progression, death, or noncomplete response with A+AVD
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Lower combined risk of progression, death, or noncomplete response with A+AVD
Only registered members have full access to PracticeUpdate content.